Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies.

MLA

Majid, Haidara, et al. “Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies.” Pharmaceutics, vol. 13, no. 9, Sept. 2021, p. 1409. EBSCOhost, https://doi.org/10.3390/pharmaceutics13091409.

APA

Majid, H., Puzik, A., Maier, T., Merk, R., Bartel, A., Mueller, H.-C., & Burckhardt, B. B. (2021). Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies. Pharmaceutics, 13(9), 1409. https://doi.org/10.3390/pharmaceutics13091409

Chicago

Majid, Haidara, Andreas Puzik, Tanja Maier, Raphaela Merk, Anke Bartel, Hans-Christian Mueller, and Bjoern B. Burckhardt. 2021. “Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies.” Pharmaceutics 13 (9): 1409. doi:10.3390/pharmaceutics13091409.